Form 4 for INCY Incyte
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0002050035-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | 2026-01-06 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | F - Tax | $106.66 | -8,264 | 77.0K | -10% | -$881.4K | |
| 2026-01-08 | 2026-01-07 | INCY | Issa Mohamed Khairie | EVP, Head of US Oncology | S - Sale | $109.07 | -10.9K | 66.1K | -14% | -$1.18M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | F | D | 8,264 | $106.66 | 76,988 | D | — | — | (F1) Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. |
| 2 | Common | Common Stock | 2026-01-07 | S | D | 10,856 | $109.07 | 66,132 | D | — | — | (F2) This includes an aggregate of 66,132 shares of common stock issuable pursuant to previously reported RSUs that have not vested. |